Exchange: NASDAQ·Updated 12:00 AM EST

ATXS News

News
all
press releases
Astria Therapeutics, Inc. (NASDAQ:ATXS) Receives Average Recommendation of "Hold" from Brokerages
Astria Therapeutics, Inc. (NASDAQ:ATXS - Get Free Report) has been given a consensus recommendation of "Hold" by the eleven ratings firms that are covering the firm, MarketBeat.com reports. One...
MarketBeat
Astria Therapeutics, Inc. (NASDAQ:ATXS) Receives Average Recommendation of "Hold" from Brokerages
Astria Therapeutics, Inc. (NASDAQ:ATXS - Get Free Report) has been given a consensus recommendation of "Hold" by the eleven ratings firms that are covering the firm, MarketBeat.com reports. One...
MarketBeat
More News
Astria Therapeutics, Inc. (Nasdaq: ATXS) today announced that at the special meeting of Astrias stockholders held on January 21, 2026, Astrias stockholders voted to approve the acquisition of Astria...
Business Wire
Astria Therapeutics, Inc. (NASDAQ:ATXS - Get Free Report) saw a significant growth in short interest in December. As of December 31st, there was short interest totaling 5,752,164 shares, a growth of...
MarketBeat
Astria Therapeutics (NASDAQ:ATXS) Shares Pass Below Fifty Day Moving Average - Should You Sell...
MarketBeat
BioCryst Pharmaceuticals (NASDAQ:BCRX) outlined a multi-pronged growth strategy at the JPMorgan Healthcare Conference, highlighting continued momentum for its hereditary angioedema (HAE) franchise, a...
MarketBeat
Halper Sadeh LLC Encourages CSGS, JHG, CWAN, ATXS Shareholders to Contact the Firm to Discuss Their Rights Halper Sadeh LLC Encourages CSGS, JHG, CWAN, ATXS Shareholders to Contact the Firm to...
PR Newswire
Astria Therapeutics, Inc. (NASDAQ:ATXS - Get Free Report) has been given a consensus recommendation of "Hold" by the eleven brokerages that are presently covering the stock, MarketBeat Ratings...
MarketBeat
$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--ATXS, MBCN, FMNB, and SEMR $HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--ATXS...
PR Newswire
JPMorgan Chase & Co. boosted its position in Astria Therapeutics, Inc. (NASDAQ:ATXS - Free Report) by 4,607.1% during the second quarter, according to its most recent 13F filing with the Securities...
MarketBeat
Panagora Asset Management Inc. acquired a new position in Astria Therapeutics, Inc. (NASDAQ:ATXS - Free Report) during the 2nd quarter, according to the company in its most recent Form 13F filing...
MarketBeat

Advertisement|Remove ads.